tetrahydrobenzo-4,6-dimethylangelicin has been researched along with 1,2,3,4-tetrahydroisoquinoline in 1 studies
Studies (tetrahydrobenzo-4,6-dimethylangelicin) | Trials (tetrahydrobenzo-4,6-dimethylangelicin) | Recent Studies (post-2010) (tetrahydrobenzo-4,6-dimethylangelicin) | Studies (1,2,3,4-tetrahydroisoquinoline) | Trials (1,2,3,4-tetrahydroisoquinoline) | Recent Studies (post-2010) (1,2,3,4-tetrahydroisoquinoline) |
---|---|---|---|---|---|
6 | 0 | 0 | 240 | 0 | 76 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Criscione, KR; Dahanukar, VH; Grunewald, GL | 1 |
1 other study(ies) available for tetrahydrobenzo-4,6-dimethylangelicin and 1,2,3,4-tetrahydroisoquinoline
Article | Year |
---|---|
Effects of a 3-alkyl-, 4-hydroxy- and/or 8-aromatic-substituent on the phenylethanolamine N-methyltransferase inhibitor potency and alpha2-adrenoceptor affinity of 2,3,4,5-tetrahydro-1H-2-benzazepines.
Topics: Animals; Enzyme Inhibitors; Furocoumarins; Isoquinolines; Male; Models, Molecular; Neurotoxins; Phenylethanolamine N-Methyltransferase; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Tetrahydroisoquinolines | 2001 |